Eromona Whiskey

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Combination Therapy

Peritoneal Dialysis

Silver Nanoparticles

Top Venues

Therapeutic advances in psychopharmacology

The British journal of psychiatry : the journal of mental science

BJPsych bulletin

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ebenezer Oloyede, Christian J Bachmann, Olubanke Dzahini, Juan Miguel Lopez Alcaraz, Shaurya Dev Singh, Kalliopi Vallianatu, Burkhardt Funk, Eromona Whiskey, David M Taylor
Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study. The British journal of psychiatry : the journal of mental science (2024)
Edward Silva, Sophie E Legge, Cecilia Casetta, Eromona Whiskey, Ebenezer Oloyede, Siobhan Gee
Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it's a CIN. BJPsych bulletin (2024)
Ebenezer Oloyede, Olubanke Dzahini, Zadro Abolou, Siobhan Gee, Eromona Whiskey, Diksha Malhotra, Masuma Hussain, Ian Osborne, Cecilia Casetta, Philip K McGuire, James Hunter MacCabe, David M Taylor
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British journal of psychiatry : the journal of mental science (2023)
Ebenezer Oloyede, Olubanke Dzahini, Zadro Abolou, Siobhan Gee, Eromona Whiskey, Diksha Malhotra, Masuma Hussain, Ian Osborne, Cecilia Casetta, Philip K McGuire, James Hunter MacCabe, David M Taylor
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British journal of psychiatry : the journal of mental science (2023)
Ebenezer Oloyede, Olubanke Dzahini, Zadro Abolou, Siobhan Gee, Eromona Whiskey, Diksha Malhotra, Masuma Hussain, Ian Osborne, Cecilia Casetta, Philip K McGuire, James Hunter MacCabe, David M Taylor
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study. The British journal of psychiatry : the journal of mental science (2023)
Ebenezer Oloyede, Ivana Clark, Shubhra Mace, Eromona Whiskey, David M Taylor
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review. Therapeutic advances in psychopharmacology 12 (2022)
Sofia Redaelli, Lilla Porffy, Ebenezer Oloyede, Olubanke Dzahini, Gabriella Lewis, Maria Lobo, Eromona Whiskey, Sukhi S Shergill
Vortioxetine as adjunctive therapy in the treatment of schizophrenia. Therapeutic advances in psychopharmacology 12 (2022)
Amir Krivoy, Eromona Whiskey, Henrietta Webb-Wilson, Dan Joyce, Derek K Tracy, Fiona Gaughran, James H MacCabe, Sukhwinder S Shergill
Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations. Therapeutic advances in psychopharmacology 11 (2021)
Eromona Whiskey, Graziella Romano, Matilda Elliott, Malcolm Campbell, Cholan Anandarajah, David M Taylor, Koravangattu Valsraj
Possible pharmacogenetic factors in clozapine treatment failure: a case report. Therapeutic advances in psychopharmacology 11 (2021)
Danielle Dunnett, Ebenezer Oloyede, Oluwakemi Oduniyi, Barbara Arroyo, Olubanke Dzahini, David M Taylor, Sukhi S Shergill, Eromona Whiskey
Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series. Journal of psychopharmacology (Oxford, England) (2021)
Eromona Whiskey, Shirley Yuen, Emma Khosla, Susan Piper, David O'Flynn, David M Taylor
Resolution without discontinuation: heart failure during clozapine treatment. Therapeutic advances in psychopharmacology 10 (2020)
Siobhan Helen Gee, Fiona Gaughran, James MacCabe, Sukhi Shergill, Eromona Whiskey, David M Taylor
Management of clozapine treatment during the COVID-19 pandemic. Therapeutic advances in psychopharmacology 10 (2020)
Farinaz Keshavarzi, Tony Fox, Eromona Whiskey, David M Taylor
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation. Therapeutic advances in psychopharmacology 10 (2020)